Skip to main content
Skip to navigation
Research Exchange
Living Lab
Discovery Lab
Donate
Prospective, multi-center post-marketing surveillance cohort study to monitor the safety of the human papillomavirus-16/18 AS04-adjuvanted vaccine in Chinese girls and women aged 9 to 45 years, 2018–2020
Hongjie Yu
· 2023-12-01
Following the approval of
Links
DOI
PubMed
Journal
Human Vaccines & Immunotherapeutics
Institutions
Fudan University
Authors
Hongjie Yu
Funding
GlaxoSmithKline Biologicals Grant 207350 or NCT03438006